Using AI to help patients with first episode psychosis take their medication
Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication
This study tests whether an AI smartphone app can help people experiencing their first episode of psychosis remember to take their medication better than standard care.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 15 Years to 40 Years |
| Sex | All |
| Sponsor | Northwell Health Academic / other |
| Locations | 5 sites (Hialeah, Florida and 4 other locations) |
| Trial ID | NCT04046497 on ClinicalTrials.gov |
What this trial studies
This project aims to utilize an artificial intelligence smartphone app to enhance medication adherence among patients experiencing their first episode of psychosis. The study addresses the significant challenge of non-adherence to oral medications, which is linked to higher rates of relapse and hospitalization. By comparing the outcomes of participants using the AI app to those receiving standard care, the study seeks to evaluate the app's acceptability and its impact on hospitalization and emergency room visits. The approach is inspired by successful monitoring techniques used in other medical fields, adapted for community settings.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals enrolled in a Coordinated Specialty Care (CSC) program who have been prescribed an oral antipsychotic.
Not a fit: Patients who are not enrolled in a CSC program or those not prescribed oral antipsychotics may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve medication adherence and reduce hospitalization rates for patients with first episode psychosis.
How similar studies have performed: Other studies have shown success with similar approaches in different medical fields, indicating potential for this novel application in mental health.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled in a CSC program * Prescribed an oral antipsychotic Exclusion Criteria: * none
Where this trial is running
Hialeah, Florida and 4 other locations
- Citrus Health — Hialeah, Florida, United States (Recruiting)
- InterAct — Grand Rapids, Michigan, United States (Recruiting)
- InterAct of Michigan — Kalamazoo, Michigan, United States (Recruiting)
- Red Rock — Oklahoma City, Oklahoma, United States (Recruiting)
- Family and Children's Services — Tulsa, Oklahoma, United States (Recruiting)
Study contacts
- Study coordinator: Patricia Marcy, BSN
- Email: pmarcy@northwell.edu
- Phone: 347-439-8035
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.